Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.

A Desai-Mehta, C Mao, S Rajagopalan… - The Journal of …, 1995 - Am Soc Clin Investig
A Desai-Mehta, C Mao, S Rajagopalan, T Robinson, SK Datta
The Journal of clinical investigation, 1995Am Soc Clin Investig
The production of potentially pathogenic anti-DNA autoantibodies in SLE is driven by
special, autoimmune T helper (Th) cells. Herein, we sequenced the T cell receptor (TCR)
alpha and beta chain genes expressed by 42 autoimmune Th lines from lupus patients that
were mostly CD4+ and represented the strongest inducers of such autoantibodies. These
autoimmune TCRs displayed a recurrent motif of highly charged residues in their CDR3
loops that were contributed by N-nucleotide additions and also positioned there by the …
The production of potentially pathogenic anti-DNA autoantibodies in SLE is driven by special, autoimmune T helper (Th) cells. Herein, we sequenced the T cell receptor (TCR) alpha and beta chain genes expressed by 42 autoimmune Th lines from lupus patients that were mostly CD4+ and represented the strongest inducers of such autoantibodies. These autoimmune TCRs displayed a recurrent motif of highly charged residues in their CDR3 loops that were contributed by N-nucleotide additions and also positioned there by the recombination process. Furthermore, Th lines from four of the five patients showed a marked increase in the usage of the V alpha 8 gene family. Several independent Th lines expressed identical TCR alpha and/or beta chain sequences indicating again antigenic selection. 10 of these Th lines could be tested further for antigenic specificity. 4 of the 10 pathogenic anti-DNA autoantibody-inducing Th lines responded to the non-histone chromosomal protein HMG and two responded to nucleosomal histone proteins; all presented by HLA-DR molecules. Another Th line responded to purified DNA more than nucleosomes. Thus, these autoimmune Th cells of lupus patients respond to charged epitopes in various DNA-binding nucleoproteins that are probably processed and presented by the anti-DNA B cells they selectively help.
The Journal of Clinical Investigation